AI Platforms Produce Melanoma Vaccine Blueprint and Protein Binders for Targeted T-Cell Therapy

De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells

AI turns immune cells into precision cancer killers—in just weeks

A breakthrough AI system is revolutionizing cancer immunotherapy by enabling scientists to design protein-based keys that train a patient s immune cells to attack cancer with extreme precision. This method, capable of reducing development time from years to weeks, was successfully tested on known and patient-specific tumor targets. Using virtual safety screenings to avoid harmful side effects, the platform represents a leap forward in personalize

BATMAN brings T cell receptor therapy out of the shadows

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks. Similarities between cancerous and healthy cells can affect the body's immune response, causing T cells to attack unintended targets.

AI-designed proteins bring personalized cancer treatment within reach

Precision cancer treatment on a larger scale is moving closer after researchers have developed an AI platform that can tailor protein components and arm the patient's immune cells to fight cancer.

An AI-Generated Protein Helps T Cells Kill Cancer

A machine learning platform cut down discovery time of a T cell-based immunotherapeutic agent from years to weeks.

AI platform designs molecular missiles to attack cancer cells

Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor protein components and arm the patient's immune cells to fight cancer.